NMCN Midwifery: Obstetric Drugs & Eclampsia Questions

NMCN Midwifery Exam: Obstetric Drug Management, Magnesium Sulphate & Eclampsia Questions

If you are preparing for the NMCN Midwifery CBT exam — whether the March or September sitting — obstetric pharmacology is one topic you cannot afford to leave to chance. Magnesium sulphate toxicity monitoring, tocolytic drugs for preterm labour, and corticosteroids for fetal lung maturity have all featured prominently in recent NMCN Midwifery papers, particularly across the 2025 sittings. This guide covers every high-yield drug concept you need, structured around how the NMCN actually tests them.

Why Obstetric Pharmacology Is a High-Priority NMCN Topic

The NMCN Midwifery CBT consists of 250 multiple-choice questions completed in a single 3-hour sitting. A significant proportion of these questions are scenario-based — you are given a clinical situation and asked what the midwife should do next. Pharmacology questions fit perfectly into this format because they test both knowledge and clinical judgement at the same time.

Analysis of recent NMCN papers shows that 30–40% of questions are either repeated or rephrased from previous sittings. In the 2025 Midwifery papers specifically, pharmacology questions related to obstetric drug management expanded noticeably, reflecting the growing emphasis on evidence-based midwifery practice in Nigerian nursing education. The standout subtopic from those sittings was magnesium sulphate toxicity — it appeared in both the March Midwifery and November General Nursing papers.

For Midwifery candidates specifically, the NMCN syllabus confirms that questions on oxytocics, tocolytics, anticonvulsants, and drugs used in obstetric emergencies are examinable. Obstetric emergencies — including eclampsia, antepartum haemorrhage, and uterine rupture — form a confirmed major exam domain.

Magnesium Sulphate (MgSO₄): The Number One Exam Topic

Eclampsia is one of the leading contributors to maternal mortality in Nigeria. In parts of northern Nigeria, maternal mortality rates exceed 1,000 deaths per 100,000 live births, with eclampsia accounting for approximately 40% of those deaths. The World Health Organization recommends magnesium sulphate as the most effective, safe, and low-cost drug for treating eclamptic seizures and for prophylaxis in severe pre-eclampsia. This clinical importance is exactly why NMCN examiners keep returning to it.

The Pritchard Regimen — Most Commonly Tested in Nigeria

The Pritchard regimen is the protocol most tested in NMCN Midwifery questions. It is a predominantly intramuscular regimen, preferred in resource-limited settings where continuous IV access may not be feasible.

• Loading dose: 4 g IV + 5 g IM into each buttock (10 g IM total)
• Maintenance dose: 5 g IM every 4 hours

An important exam point: the Pritchard regimen does not cure eclampsia — it controls convulsions and buys time for delivery. The definitive treatment for eclampsia is delivery of the baby.

MgSO₄ Toxicity — The Most-Tested Subtopic

The NMCN examiners consistently test whether you can identify the signs of magnesium sulphate toxicity and know what to do when they appear. Master this three-sign framework:

1. Patellar (Knee-Jerk) Reflex This is the first sign of toxicity to appear. Before giving any dose of MgSO₄, check the patellar reflex. If it is absent, stop the drug immediately — do not wait for other signs to develop.

2. Respiratory Rate Count the respiratory rate before every dose. The respiratory rate must be above 12 breaths per minute. A rate below 12 indicates toxicity. MgSO₄ is a respiratory depressant, and failure to monitor breathing is a serious clinical error.

3. Urine Output Always pass a urethral catheter with an attached urine bag before commencing the Pritchard regimen. Adequate urine output confirms that the kidneys are clearing the drug. Reduced urine output is a toxicity sign and a red flag, especially in women with coexisting renal impairment.

The Antidote: Calcium Gluconate Every patient on MgSO₄ must have 1 g of calcium gluconate drawn up and ready at the bedside. If any sign of toxicity appears, administer calcium gluconate immediately by slow IV injection.

Serum Level Reference (for higher-order questions):

• Therapeutic range: 4–7 mEq/L
• Loss of patellar reflex, flushing, somnolence: 8–12 mEq/L
• Muscular paralysis and respiratory difficulty: 15–17 mEq/L

⚠️ Special Risk: Women with renal impairment are at significantly higher risk of magnesium toxicity. If a question mentions oliguria or renal compromise alongside MgSO₄ use, treat it as a toxicity scenario.

Antihypertensives Used Alongside MgSO₄

MgSO₄ controls seizures — it does not adequately lower blood pressure. The NMCN also tests knowledge of the antihypertensive agents used in severe pre-eclampsia/eclampsia:

• Hydralazine IV: Arterial vasodilator; takes 20–30 minutes to act, peak in 30–60 minutes. Associated with more side effects including maternal hypotension and fetal heart rate abnormalities.
• Labetalol IV/oral: Faster onset (5–10 minutes), peak in 5–15 minutes.
• Nifedipine oral: Most effective for blood pressure reduction with a single dose but may require additional doses.

For exam purposes, know that IV hydralazine carries more adverse effects compared to nifedipine and labetalol based on comparative evidence.

Tocolytics: Managing Preterm Labour

Tocolytic drugs are used to delay preterm delivery — specifically to create a 48-hour window that allows antenatal corticosteroids to take effect and facilitates transfer to a facility with specialised neonatal care. Understanding the purpose of tocolysis is itself a testable concept.

Key Tocolytic Agents for the NMCN Exam

Nifedipine (Calcium Channel Blocker) Nifedipine is the most practical first-line tocolytic in resource-limited Nigerian settings due to its low cost and oral availability. Studies show no documented fetal risks with nifedipine use for preterm labour management. Use with caution in women with hypotension or cardiac conditions.

Atosiban (Oxytocin Receptor Antagonist) Atosiban works by competitively blocking the oxytocin receptor, thereby reducing uterine contractions. It has a strong evidence base and no reported serious adverse effects. However, it is significantly more expensive and not universally available in Nigerian public health facilities.

Comparative Exam Point: Evidence suggests atosiban is as effective as nifedipine and safer than beta-agonists. However, NMCN questions in the Nigerian context are most likely to test nifedipine as the practical first-line agent. Confirm current clinical guidelines with your institution's obstetric protocols.

Corticosteroids for Fetal Lung Maturity

Antenatal corticosteroids accelerate fetal lung maturity in preterm pregnancies and are a confirmed testable topic in NMCN Midwifery pharmacology.

Which Drugs?

The two recommended agents are betamethasone and dexamethasone. Both are given intramuscularly and are indicated for pregnancies between 23 and 37 weeks of gestation. They are preferred because of their resistance to degradation by placental metabolic enzymes.

Dosing Regimens — High-Yield for MCQs

Timing of Maximum Benefit

The maximum benefit from antenatal corticosteroids occurs between 24 hours and 7 days after the first dose. This is why the 48-hour tocolytic window is so clinically important — it allows the corticosteroids to reach peak effect.

Critical exam point: Even if a second dose is unlikely to be given, the first dose should still be administered. Partial treatment still significantly reduces neonatal morbidity and mortality. If an NMCN question asks whether to give the corticosteroid when delivery seems imminent, the answer is yes — give it anyway.

Research comparing dexamethasone versus betamethasone in late preterm delivery has been conducted at Ahmadu Bello University Teaching Hospital, Zaria — confirming the Nigeria-specific clinical relevance of this topic.

Quick-Reference Summary Table

FAQ: NMCN Midwifery Obstetric Drug Questions

What is the antidote for magnesium sulphate toxicity in the NMCN exam?

The antidote is calcium gluconate 1 g, given by slow intravenous injection. Every woman receiving MgSO₄ must have this prepared and ready at the bedside before treatment begins. This is one of the most consistently tested facts in NMCN Midwifery pharmacology.

What are the three signs of MgSO₄ toxicity I must know for the NMCN?

The three key monitoring parameters are: (1) the patellar (knee-jerk) reflex — absence indicates toxicity; (2) respiratory rate — must remain above 12 breaths per minute; and (3) urine output — reduced output signals the drug is not being cleared adequately. If any of these signs appear, stop MgSO₄ immediately and give calcium gluconate.

Which tocolytic is most likely to appear in NMCN Midwifery questions?

Based on recent exam trends and the Nigerian clinical context, nifedipine is the most likely first-line tocolytic to be tested. It is an oral calcium channel blocker used to delay preterm delivery for 48 hours to allow corticosteroids to work. Confirm the current protocol with your clinical placement facility.

What is the difference between betamethasone and dexamethasone in preterm labour?

Both drugs are antenatal corticosteroids used to accelerate fetal lung maturity between 23–37 weeks. The key difference is in dosing: betamethasone is given as 12 mg IM every 24 hours for two doses, while dexamethasone is given as 6 mg IM every 12 hours for four doses. Both achieve the same clinical goal. Maximum benefit occurs between 24 hours and 7 days after the first dose.

Does the Pritchard regimen cure eclampsia?

No — this is a common misconception that the NMCN may test. The Pritchard regimen controls convulsions but does not cure eclampsia. The definitive cure is delivery of the baby. MgSO₄ is used to stabilise the patient and prevent further seizures while preparing for delivery.

Start Practising These Questions Today with PassMate

Knowing the theory is only half the battle — the NMCN CBT rewards candidates who have practised applying this knowledge to clinical scenarios under timed conditions. That is exactly what PassMate is built for. PassMate offers NMCN-aligned practice questions covering obstetric pharmacology, eclampsia management, tocolytics, corticosteroids, and every other high-yield Midwifery topic — all in a realistic CBT format that mirrors the actual exam experience.

Whether you are sitting in March or September, start your PassMate practice sessions now. The candidates who pass the NMCN are not just those who read — they are the ones who practise until the right answers become instinct.

Visit PassMate today and start your NMCN Midwifery preparation.